Surfactant therapy in infants and children: Three years experience in a pediatric intensive care unit

Shock

Volumn 17, Issue 4, 2002, Pages 247-251

  Hermon, Michael M ^b   Golej, Johann ^c   Burda, Gudrun ^c   Boigner, Harald ^c   Stoll, Elisabeth ^c   Vergesslich, Klara ^c   Strohmaier, Wolfgang ^a   Pollak, Arnold ^c   Trittenwein, Gerhard ^c  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b Währinger Gürtel 18 20 5P   (Austria)

^c NONE

Author keywords

Acute respiratory distress syndrome; Hypoxemia score; Lung injury score; Oxygenation index

Indexed keywords

BIOLOGICAL PRODUCT; LIPID; LUNG SURFACTANT; PHOSPHOLIPID; PORACTANT; SF RI 1, BOVINE SURFACTANT PREPARATION; SF-RI 1, BOVINE SURFACTANT PREPARATION;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; AUSTRIA; DRUG EFFECT; FEMALE; HEART SURGERY; HUMAN; INFANT; INTENSIVE CARE; LUNG; LUNG FUNCTION TEST; MALE; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

AUSTRIA; BIOLOGICAL PRODUCTS; CARDIAC SURGICAL PROCEDURES; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; LIPIDS; LUNG; MALE; PHOSPHOLIPIDS; POSTOPERATIVE COMPLICATIONS; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES;

EID: 0036551161     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200204000-00001     Document Type: Article

References (35)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet 2:319-323, 1967.
2. DeBruin W, Notterman DA, Magid M, Godwin T, Johnston S: Acute hypoxemic respiratory failure in infants and children: clinical and pathologic characteristics. Crit Care Med 20:1223-1234, 1992.
3. Timmons OD, Dean JM, Vernon DD: Mortality rates and prognostic variables in children with adult respiratory distress syndrome. J Pediat 119:896-899, 1991.
4. Evans DA, Wilmott RW, Whitsett JA: Surfactant replacement therapy for adult respiratory distress syndrome in children. Ped Pulmonol 21:328-336, 1996.
5. 2 removal for adult respiratory distress syndrome. Am J Resp Crit Care Med 149:295-305, 1994.
6. Arnold JH, Hanson JH, Toro-Figuero LO, Gutierrez J, Berens RJ, Anglin DL: Prospective, randomized comparison of high frequency oscillatory ventilation and conventional mechanical ventilation in paediatric respiratory failure. Crit Care Med 22:1530-1539, 1994.
7. Hickling KG, Walsh J, Henderson S, Jackson R: Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med 22:1568-1578, 1994.
8. Murdoch IA, Storman MO: Improved arterial oxygenation in children with the adult respiratory distress syndrome: the prone position. Acta Paediat 83:1043-1046, 1994.
9. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399-405, 1993.
10. Moler FW, Custer JR, Bartlett RH, Palmisano JM, Akingbola O, Taylor RP, Maxvold NJ: Extracorporeal life support for severe paediatric respiratory failure: an update experience, 1991-1993. J Ped 124:875-880, 1994.
11. Davis SL, Furman DP, Costarino AT: ARDS in children: associated disease, clinical course, and predictors of death. J Pediat 123:35-45, 1993.
12. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA, Hudson LD, Maunder RJ, Crim C, Hyers TM: Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88:1976-1981, 1991.
13. Collaborative European Multicenter Study Group: Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics 82:683-691, 1988.
14. Merritt TA, Mailman M, Bloom BT, Berry C, Benirschke K, Sahn D, Key T, Edwards D, Jarvenpaa AL, Pohjavuori M: Prophylactic treatment of very premature infants with human surfactant. N Engl J Meet 315:785-790, 1986.
15. Gitlin JD, Soil RF, Parad RB, Horbar JD, Feldman HA, Lucey JF, Taeusch HW: Randomized controlled trial of exogenous surfactant for treatment of hyaline membrane disease. Pediatrics 79:31-37, 1987.
16. Kattwinkel J, Bloom BT, Delmore P, Davis CL, Farrell E, Friss H, Jung AL, King K, Mueller D: Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Pediatrics 92:90-98, 1993.
17. Murray JF, Matthay MA, Luce JM, Flick MR: An expanded definition of the adult respiratory distress syndrome. Am Rev Resp Dis 138:720-723, 1988.
18. Petty TL: ARDS: refinement of concept and redefinition. Am Rev Resp Dis 138:724, 1988.
19. Willson DF, Zaritsky A, Bauman LA, Dockery K, James RL, Conrad D, Craft H, Novotny WE, Egan EA, Dalton H: Instillation of calf lung surfactant extract (calfactant) is beneficial in paediatric acute hypoxemic respiratory failure. Crit Care Med 27:188-195, 1999.
20. Willson DF, Jiao JH, Bauman LA, Zaritsky A, Craft H, Dockery K, Conrad D, Dalton H: Calf's lung surfactant in acute hypoxemic respiratory failure in children. Crit Care Med 24:1316-1322, 1996.
21. Pison U, Seeger W, Buchhorn R, Joka T, Brand M, Obertacke U, Neuhof H, Schmit-Neuerburg KP: Surfactant abnormalities in patients with respiratory failure after multiple traumas. Am Rev Resp Dis 140:1033-1039, 1989.
22. Lachmann B: Surfactant replacement in acute respiratory failure: animal studies and first clinical trials. In Lachmann B (ed): Surfactant Replacement Therapy in Neonatal and Adult RDS. New York: Springer-Verlag, 1987, pp 204-211.
23. Levine AM, Lotze A, Stanley S, Stroud C, ODonnell R, Whitsett J, Pollack MM: Surfactant content in children with inflammatory lung disease . Crit Care Med 24:1062-1067, 1996.
24. Lopez-Herce J, de Lucas N, Carrillo A, Bustinza A, Moral R: Surfactant treatment for acute respiratory distress syndrome. Arch Dis Child 80:248-252, 1999.
25. McGowan FX Jr., Ikegami M, del Nido PJ, Motoyama EK, Kurland G, Davis PJ, Siewers RD: Cardiopulmonary bypass significantly reduces surfactant activity in children. J Thorac Cardiovasc Surg 106:968-977, 1993.
26. Ratliff NB, Young WG, Hackel DB, Mikat E, Wilson JW: Pulmonary injury secondary to extracorporeal circulation. J Thorac Cardiovasc Surg 65:425-432, 1997.
27. Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventos AA, Lemaire F, Long W, Zaccardelli DS, Pattishal EN: Aerosolized surfactant in adults with sepsis induced acute respiratory distress syndrome. N Engl J Med 334:1417-1421, 1996.
28. Segerer H, Van Gelder W, Angenent FW, van Woerkens LJ, Curstedt T, Obladen M, Lachmann B: Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by instillation technique. Pediat Res 34:490-494, 1993.
29. Segerer H, Scheid A, Wagner M, Obladen M: Tracheal surfactant infusion during 5 minutes is less effective than bolus instillation in rabbits. Pediat Res 36:37 A, 1994.
30. Notter RH, Egan EA, Kwong MA, Holm BA, Shapiro DL: Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: effects of dose, dispersion technique, and gestational age. Pediat Res 19:569-577, 1985.
31. Jobe A: Protein leaks and surfactant dysfunction in the pathogenesis of respiratory distress syndrome. Eur Resp J 3(Suppl):27s-32s, 1989.
32. Holm BA, Enchorning G, Notter RH: A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phvs Lipids 49:49-55, 1988.
33. Gilliard N, Richman PM, Merritt TA, Spragg RG: Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury. Am Rev Resp Dis 141:743-747, 1990.
34. Meister JC, Balaraman V, KU T, DeSilva A, Sood S, Uyehare CF, Person DA, Easa D: Lavage administration of diluted recombinant surfactant in acute lung injury in piglets. Pediat Res 47:240-245, 2000.
35. Strohmaier W, Schlag G: Lung lavage with diluted surfactant is as effective as bolus treatment in a rabbit long-term aspiration model. Appl Cardiopulm Pathophysiol 7:17-22, 1998.